Murdoch Childrens Research Institute
Clinical trials sponsored by Murdoch Childrens Research Institute, explained in plain language.
-
Can a smaller booster dose still protect against COVID-19?
⭐️ VACCINE ⭐️ CompletedThis study looked at whether a smaller (fractional) dose of the Pfizer-BioNTech COVID-19 booster works as well as the standard dose. It involved 601 healthy adults in Mongolia who had already received two doses of Sinopharm, AstraZeneca, or Sputnik vaccines 6 to 9 months earlier.…
Phase: PHASE3 • Sponsor: Murdoch Childrens Research Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC
-
Egg ladder could help babies beat egg allergy at home
Disease control CompletedThis study tested a home-based, dietitian-led 'egg ladder' for infants newly diagnosed with egg allergy. Over 12 months, babies gradually ate more cooked egg, starting with baked goods. The goal was to see if this approach is safe and feasible. 109 infants participated, and resea…
Phase: NA • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can kids with cancer stop antibiotics sooner? new trial investigates
Disease control CompletedThis study looked at whether children with cancer and a fever caused by low white blood cells can safely stop antibiotics earlier than usual. 55 children took part, and half stopped antibiotics once their fever was gone for 48 hours, while the other half continued until their whi…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Tiny doses, big hope: new therapy may help kids outgrow nut allergies
Disease control CompletedThis study tested a low-dose oral immunotherapy (OIT) in children aged 18-36 months with allergies to two nuts. Over 18 months, one group received daily tiny doses of the nuts they were allergic to, while the other group avoided them completely. The goal was to see if more childr…
Phase: NA • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Nose spray could block COVID spread in homes
Prevention CompletedThis study tested a nose spray containing heparin, a common and safe medicine, to see if it could stop the spread of COVID-19 within households. Over 500 people who lived with someone who tested positive for COVID-19 used the spray or a dummy spray three times a day for 10 days. …
Phase: PHASE2, PHASE3 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Nutty idea: early tree nut exposure may shield Peanut-Allergic babies
Prevention CompletedThis study tested whether giving tree nuts early to infants with peanut allergy could prevent them from developing tree nut allergies. 212 babies aged 4-11 months were split into two groups: one had a supervised hospital challenge with four tree nuts followed by home introduction…
Phase: PHASE3 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Labour antibiotic may shield newborns from infections
Prevention CompletedThis study tested whether giving mothers a single 2-gram dose of the antibiotic azithromycin during labour could reduce the risk of skin and soft tissue infections in their babies during the first three months of life. Over 2,000 pregnant women in Fiji took part, receiving either…
Phase: PHASE3 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated Jun 26, 2026 14:38 UTC
-
Could a common ADHD drug improve speech in kids with apraxia?
Symptom relief CompletedThis study tested whether methylphenidate, a drug often used for ADHD, can help children aged 6 to 12 with childhood apraxia of speech speak more clearly. The trial involved 18 children who took the drug or a placebo in a crossover design. The main goal was to see if the drug imp…
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Snoring kids may skip surgery: nasal spray trial shows promise
Symptom relief CompletedThis study tested a steroid nasal spray (mometasone furoate) in 130 children aged 3-12 who snore and have sleep-disordered breathing. The goal was to see if the spray could relieve symptoms enough to avoid surgery to remove tonsils or adenoids. Children used the spray daily for 6…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
CBD oil studied as a treatment for severe behavioral issues in kids with intellectual disability
Symptom relief CompletedThis study tested whether cannabidiol (CBD) oil can reduce severe behavioral problems in children aged 6-18 with intellectual disability. 132 participants received either CBD or a placebo for 8 weeks. The main goal was to see if CBD improves irritability and other challenging beh…
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 26, 2026 13:23 UTC
-
Scientists deliberately give volunteers strep throat to speed up vaccine development
Knowledge-focused CompletedThis completed early-phase study tested a new way to study Strep A bacteria, which causes strep throat and can lead to serious heart disease. Researchers safely exposed 40 healthy adults aged 18-40 to a specific strain of Strep A under controlled conditions. The goal was to see h…
Phase: EARLY_PHASE1 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC